NCT07687628 Camera-based Endoscopy Allows Spontaneous Breathing Diagnostic Management in Neonates With Tracheoesophageal Fistula
| NCT ID | NCT07687628 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Papa Giovanni XXIII Hospital |
| Condition | Tracheoesophageal Fistula |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-10-01 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to compare rigid tracheoscopy versus flexible tracheo-video-endoscopy in neonates requiring diagnostic assessment before undergoing a congenital tracheoesophageal fistula repair.
Eligibility Criteria
Inclusion Criteria: * Neonates who have undergone surgical repair of esophageal atresia with or without tracheoesophageal fistula at ASST Papa Giovanni XXIII, Bergamo, from 1 January 2013 onwards * Written informed consent signed by both parents or legal guardian Exclusion Criteria: * Refusal or inability to obtain informed consent from parents or legal guardian
Contact & Investigator
Ezio Bonanomi, MD
STUDY CHAIR
A.O. Ospedale Papa Giovanni XXIII
Frequently Asked Questions
Who can join the NCT07687628 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 28 Days, studying Tracheoesophageal Fistula. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07687628 currently recruiting?
Yes, NCT07687628 is actively recruiting participants. Contact the research team at smariconti@asst-pg23.it for enrollment information.
Where is the NCT07687628 trial being conducted?
This trial is being conducted at Bergamo, Italy.
Who is sponsoring the NCT07687628 clinical trial?
NCT07687628 is sponsored by Papa Giovanni XXIII Hospital. The principal investigator is Ezio Bonanomi, MD at A.O. Ospedale Papa Giovanni XXIII. The trial plans to enroll 60 participants.